P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

September 2012

Features

The Nanomedicine Revolution

Part 1: Emerging Concepts

Nanoparticles may soon be used to transport diagnostic and therapeutic drugs to targeted sites not normally accessible, thereby improving treatment and reducing costs. Further research is still needed to establish the efficacy and safety of these nanomaterials.
C. Lee Ventola, MS

Role of Alvimopan (Entereg) in Gastrointestinal Recovery and Hospital Length of Stay After Bowel Resection

A retrospective chart review revealed that patients receiving alvimopan after bowel surgery had faster recovery times, better surgical care, and lower costs of care compared with patients who did not receive the drug.
Shan Wang, PharmD, RPh; Neal Shah, PharmD Candidate; Jessin Philip, PharmD, RPh; Tom Caraccio, PharmD; Martin Feuerman, MS; and Brian Malone, MS, RPh

Meeting Highlights

Second European Post-Chicago Melanoma Meeting 2012

Selected topics include targeted and chemotherapeutic agents (darafenib, trametinib), immunotherapies (ipilimumab, T-VEC, Rose Bengal), and the continuing role of single-agent and combination chemotherapy.
Walter Alexander

Departments

Letters to the Editor

Makena or Compounded 17P?; Clarification on Hydrocodone (Zohydro)

Medication Errors

Safeguards for Using and Designing Automated Dispensing Cabinets

Automated dispensing cabinets have had a mixed record on improving drug safety.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Pharmacists Welcome FDA’s Opioids REMS

How Directly Will They Be Affected?

Pharmacists will need to become well versed in the FDA’s REMS for opioids.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Lorcaserin (Belviq), an appetite suppressant; pertuzumab (Perjeta) for HER-2–positive metastatic breast cancer; MenHibrix vaccine for meningococcal infections and influenza; icosapent ethyl (Vascepa) for reducing triglycerides; and aclidinium inhalation (Tudorza) powder for bronchospasm in COPD
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Ipilimumab (Yervoy) Prolongs Survival In Advanced Melanoma

Serious Side Effects and a Hefty Price Tag May Limit Its Use

Chris Fellner